Inogen (INGN) Asset Writedowns and Impairment (2013 - 2026)
Inogen (INGN) reported Asset Writedowns and Impairment of $416000.0 for Q1 2026, up 150.6% year-over-year from $166000.0 in Q1 2025, and up 311.88% quarter-over-quarter from $101000.0 in Q4 2025.
Inogen (INGN) Asset Writedowns and Impairment (2013 - 2026) Analysis & Trends
Inogen (INGN) has 14 years of Asset Writedowns and Impairment data on file, last reported at $416000.0 in Q1 2026.
- Asset Writedowns and Impairment for Q1 2026 came in at $416000.0, up 150.6% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 million (up 137.17% YoY), and the FY2025 annual result was $822000.0, up 252.79% from the prior year.
- Asset Writedowns and Impairment rose to $416000.0 in Q1 2026 per INGN's latest filing, from $101000.0 in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $1.4 million in Q3 2023 and troughed at -$317000.0 in Q3 2024.
- A 5-year average of $387352.9 and a median of $363000.0 in 2022 frame the typical range for Asset Writedowns and Impairment.
- The sharpest annual moves came in 2024 and 2025: Asset Writedowns and Impairment slumped 123.41% in 2024, then soared 413.21% in 2025.
- A 5-year view of Asset Writedowns and Impairment shows it stood at $363000.0 in 2022, then fell by 4.13% to $348000.0 in 2023, then soared by 36.78% to $476000.0 in 2024, then slumped by 78.78% to $101000.0 in 2025, then surged by 311.88% to $416000.0 in 2026.
- Business Quant data shows INGN's Asset Writedowns and Impairment at $416000.0 in Q1 2026, $101000.0 in Q4 2025, and $274000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Inogen | 176.23 Mn | 81.82 Mn | 37.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 416,000.00 |
| Mar 31, 2026 | 416,000.00 |
| Dec 31, 2025 | 101,000.00 |
| Dec 31, 2025 | 101,000.00 |
| Sep 30, 2025 | 274,000.00 |
| Sep 30, 2025 | 274,000.00 |
| Jun 30, 2025 | 281,000.00 |
| Jun 30, 2025 | 281,000.00 |
| Mar 31, 2025 | 166,000.00 |
| Mar 31, 2025 | 166,000.00 |
| Dec 31, 2024 | 476,000.00 |
| Dec 31, 2024 | 476,000.00 |
| Sep 30, 2024 | -317,000.00 |
| Sep 30, 2024 | -317,000.00 |
| Jun 30, 2024 | 127,000.00 |
| Jun 30, 2024 | 127,000.00 |
| Mar 31, 2024 | -53,000.00 |
| Mar 31, 2024 | -53,000.00 |
| Dec 31, 2023 | 348,000.00 |
| Dec 31, 2023 | 348,000.00 |